scispace - formally typeset
M

Martin Renatus

Researcher at Novartis

Publications -  55
Citations -  5859

Martin Renatus is an academic researcher from Novartis. The author has contributed to research in topics: Caspase & Plasminogen activator. The author has an hindex of 18, co-authored 51 publications receiving 5491 citations. Previous affiliations of Martin Renatus include Sanford-Burnham Institute for Medical Research & École Normale Supérieure.

Papers
More filters
Journal ArticleDOI

A unified model for apical caspase activation.

TL;DR: A unified caspase activation hypothesis is proposed whereby apical caspases are activated by dimerization of monomeric zymogens, and single amino acid substitutions at the dimer interface abrogate the activity of caspased-8 and -9 introduced into recipient mammalian cells.
Journal ArticleDOI

Structural Basis for the Inhibition of Caspase-3 by XIAP

TL;DR: The crystal structure of the second BIR domain of XIAP (BIR2) in complex with caspase-3, at a resolution of 2.7 A, is reported, revealing the structural basis for inhibition and the mechanism of inhibition is due to a steric blockade prohibitive of substrate binding.
Journal ArticleDOI

Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.

TL;DR: In this article, the crystal structures of a dengue NS2B-NS3pro complex and a West Nile virus NS2b-NS 3pro complex with a substrate-based inhibitor were reported.
Journal ArticleDOI

Dimer formation drives the activation of the cell death protease caspase 9.

TL;DR: Observations support a model in which recruitment by Apaf-1 creates high local concentrations of caspase 9 to provide a pathway for dimer-induced activation, with interactions at the dimer interface promoting reorientation of the activation loop.